These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 33000197)

  • 1. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
    Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X
    Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression and clinical prognostic value of protein phosphatase 1 catalytic subunit beta in pancreatic cancer.
    Hu L; Xu H; Wang X; Wu B; Chen F; Chen W; Gao Y; Zhong Z
    Bioengineered; 2021 Dec; 12(1):2763-2778. PubMed ID: 34125004
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
    Front Immunol; 2022; 13():805311. PubMed ID: 35154122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis.
    Xu D; Wang Y; Zhou K; Wu J; Zhang Z; Zhang J; Yu Z; Liu L; Liu X; Li B; Zheng J
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33169793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
    Yan C; Niu Y; Li F; Zhao W; Ma L
    J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
    Shi T; Gao G
    Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma.
    Zheng X; Liu X; Zheng H; Wang H; Hong D
    Int Immunopharmacol; 2021 Jan; 90():106982. PubMed ID: 33129696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N6-Methyladenosine- (m6A-) Associated Genes Act as Strong Key Biomarkers for the Prognosis of Pancreatic Adenocarcinoma.
    Li F; Zhang P
    Comput Math Methods Med; 2021; 2021():8715823. PubMed ID: 34840598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GNG7 and ADCY1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma through bioinformatic-based analyses.
    Zhang Y; Yang J; Wang X; Li X
    Sci Rep; 2021 Oct; 11(1):20441. PubMed ID: 34650124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weighted Gene Co-Expression Network Analysis Reveals Six Hub Genes Involved in and Tight Junction Function in Pancreatic Adenocarcinoma and their Potential Use in Prognosis.
    Xia WX; Zhang LH; Liu YW
    Genet Test Mol Biomarkers; 2019 Dec; 23(12):829-836. PubMed ID: 31821092
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancer.
    Yin L; Xiao L; Gao Y; Wang G; Gao H; Peng Y; Zhu X; Wei J; Miao Y; Jiang K; Lu Z
    Med Oncol; 2020 Apr; 37(5):46. PubMed ID: 32277286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis.
    Xie J; Peng Y; Chen X; Li Q; Jian B; Wen Z; Liu S
    PLoS One; 2021; 16(1):e0245908. PubMed ID: 33507917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological Characteristics, Prognosis, and Correlated Tumor Cell Function of Tropomodulin-3 in Pancreatic Adenocarcinoma.
    Zhong B; Ma DD; Zhang T; Gong Q; Dong Y; Zhang JX; Li ZH; Jin WD
    Comb Chem High Throughput Screen; 2024; 27(7):1011-1021. PubMed ID: 37563820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrate analysis of the promote function of Cell division cycle-associated protein family to pancreatic adenocarcinoma.
    Xing C; Wang Z; Zhu Y; Zhang C; Liu M; Hu X; Chen W; Du Y
    Int J Med Sci; 2021; 18(3):672-684. PubMed ID: 33437202
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets.
    Liu L; Wang S; Cen C; Peng S; Chen Y; Li X; Diao N; Li Q; Ma L; Han P
    Mol Med Rep; 2019 Aug; 20(2):1901-1914. PubMed ID: 31257501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDNF Acts as a Prognostic Factor Associated with Tumor-Infiltrating Th2 Cells in Pancreatic Adenocarcinoma.
    Zhu Y; Zhang C; Zhao D; Li W; Zhao Z; Yao S; Zhao D
    Dis Markers; 2021; 2021():7842035. PubMed ID: 34777634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and prognostic values of MET expression in pancreatic adenocarcinoma based on bioinformatics analysis.
    Yao Y; Zhan R; Gong C; Lv J; Lu X
    Medicine (Baltimore); 2023 Oct; 102(41):e34656. PubMed ID: 37832054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.